Sol-Gel Reports First Quarter 2024 Financial Results And Provides Corporate Updates
Source: menafn.com
Stay updated with breaking news from Gel Contact. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(2024-04-01 | NDAQ:SLGL) Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
NESS ZIONA, Israel, April 01, 2024 -- Sol-Gel Technologies, Ltd. , a dermatology company pioneering treatments for patients with severe skin conditions, conducting a Phase 3 clinical trial of...
An ongoing phase 3 clinical trial of SGT-610 for Gorlin Syndrome with the first patient screened; Results are expected by the end of 2025 Sol-Gel ...
(2024-03-13 | NDAQ:SLGL) Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments